Summary:

- The UK government has announced plans to fund a new blood test that can detect up to 12 of the most common types of cancer, even before symptoms appear.
- The test, developed by the company Grail, uses advanced genomic sequencing technology to analyze fragments of DNA in the bloodstream to identify early signs of cancer.
- If successful, this test could revolutionize cancer screening and early detection, potentially saving thousands of lives by allowing for earlier treatment and intervention.